Revision of the Hip Joint - Prospective Study

The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2012 by Hadassah Medical Organization.
Recruitment status was  Not yet recruiting
Sponsor:
Information provided by (Responsible Party):
Hadassah Medical Organization
ClinicalTrials.gov Identifier:
NCT01655355
First received: July 30, 2012
Last updated: July 31, 2012
Last verified: July 2012
  Purpose

Between the years 1999-2011 70 patients went through a revision of the hip joint(revision after not successful Total or Partial Hip Replacement). During the revision the Acetabular implant was found to be stable and it was decided not to replace it. The polyethylene insert was replaced and was fixated using a cement. Our purpose is to evaluate the physical condition of these patients.


Condition
Revision of the Hip Joint

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective

Further study details as provided by Hadassah Medical Organization:

Primary Outcome Measures:
  • Quality of life [ Designated as safety issue: No ]
    Quality of life as measured by the SF12 questionnaire.


Secondary Outcome Measures:
  • Function [ Designated as safety issue: No ]
    Function as measured by the Haris Hip Score


Groups/Cohorts
Revison of the hip joint

  Eligibility

Ages Eligible for Study:   45 Years to 85 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients that underwent a revision of the hip replacement without removing the acetabular implant.

Criteria

Inclusion Criteria:

  1. Patients that underwent a revision of the hip replacement without removing the acetabular implant
  2. Insert polyethylene with cement
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01655355

Contacts
Contact: Gurion Rivkin 972-2-6776342 Gurion@hadassah.org.il

Locations
Israel
Hadassah Medical Organization Not yet recruiting
Jerusalem, Israel
Sponsors and Collaborators
Hadassah Medical Organization
  More Information

No publications provided

Responsible Party: Hadassah Medical Organization
ClinicalTrials.gov Identifier: NCT01655355     History of Changes
Other Study ID Numbers: rivk-001-HMO-CTIL
Study First Received: July 30, 2012
Last Updated: July 31, 2012
Health Authority: Israel: Ministry of Health

ClinicalTrials.gov processed this record on July 29, 2014